posted on Dec, 27 2008 @ 08:22 PM
Latest press release from Brigitte.
Brigitte Boisselier breaks 5-year silence, offers to ease cloning costs for Clonaid clients willing to go public Six years to the day after the
birth of Baby Eve, the first cloned child, Dr. Brigitte Boisselier, head of the company that leads the Clonaid project, said Eve and other babies
cloned by her company are growing up healthy and normal - and with no one invading their families' privacy.
"We've helped almost 100 families who were desperate to have a child," Boisselier said. "Our reward has been to see a number of cloned babies
growing up normally, like any infant born through natural reproduction or through in vitro fertilization." But she said the time has come to take
things a step further.
"As of now, the Clonaid and Stemaid teams are ready to facilitate the cloning of one or more additional individuals at a reduced rate, provided they
would agree - under contract - to go public after being cloned," Boisselier said. "We believe this is the right time to show publicly what we can do
and offer the proof people wanted after the birth of Baby Eve." She said many types of clients can benefit from her company's cloning technology.
"We can give hope to infertile and homosexual couples, to people who've lost a beloved family member and to single men and women who want a child
created exclusively from their own genes," Boisselier said. "And we can also help those who suffer from ailments that can be cured with their own
stem cells." In addition, Boisselier announced the team's 500th clone blastocyst.
"Back in early 2002 when we had our first human clone blastocysts, we needed an average of 30 human eggs to get one good blastocyst," Boisselier
"Now, after seven years of practice, for every three eggs fused, we can repeatedly prepare one clone blastocyst. This is a milestone achievement."
Boisselier said 70 percent of the refined cloning technology developed by Clonaid scientists is now used for the preparation of embryonic stem cells
made available through Clonaid's sister company, Stemaid (www.stemaid.com).
"I was tremendously moved by the happiness of those we've helped to have children through our cloning project," she said. "But I was probably even
more touched when I saw a Stemaid patient who had had a stroke and then was treated with embryonic stem cells created through our cloning technology.
After having several years of impaired speech, she was able to speak normally again." Boisselier said that when her 2002 announcement of the first
cloned baby was treated as a hoax after the parents decided not to go public, she chose to respect the privacy requests of other such parents as
"In doing so, I gained the trust of all future Clonaid patients as well as the necessary privacy to develop the technology further," she explained.
"But we've come a long way since then. It's time to show the world the proof of what we're doing."